Stiripentol for the treatment of super-refractory status epilepticus with cross-sensitivity
Acta Neurologica Scandinavica Jan 10, 2018
Uchida Y, et al. - An analysis was performed to investigate the optimal antiepileptic drug (AED) for treating super-refractory status epilepticus (SRSE) with cross-sensitivity. In adults with SRSE, cross-sensitivity between AEDs was common. For treating SRSE with cross-sensitivity, stiripentol (STP) could be useful.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
